Sort by
Refine Your Search
-
algorithms, clinical decision support systems, and population health management platforms. Evaluate emerging technologies in clinical informatics and provide strategic recommendations for their adoption within
-
. Multiple translational clinical studies seek to address these themes through our collaborators in the Royal Marsden. Overall, our mission is to cure more patients with fewer immediate and long-term side
-
clear data presentation, ability to work efficiently in a team and with collaborators Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage Previous
-
visit here . As a successful candidate you will: · Focus on metabolic regulations of cardiovascular disease under cancer treatment and metabolic syndrome · Utilize multiple cutting-edge
-
), Blood Cancer Journal (2022), Cell Stem Cell (2018). The Li research program is supported by multiple NIH (R01s), American Cancer Society, The Alex’s Lemonade Stand Foundation and several other prestigious
-
or externally. Ability to work in a fast-paced team environment and handle multiple projects simultaneously. Your qualifications should include: Ph.D., MD, or MD/Ph.D., with a strong background and profound
-
and excellence as documented by peer-reviewed publications. Ability to work in a fast-paced research environment and manage multiple projects and collaborations. Strong team player with excellent
-
imaging techniques and/or behavioral testing in rodents is advantageous. It is an advantage to have expertise in genetic cell tracing techniques. Experience in managing mouse colonies with multiple
-
multiple prestigious awards, including the NIH MERIT Award, Mathers Foundation Award, V Scholar Award, MRA Young Investigator Award, and ACS Catalyst Award, among others. Ideal Candidate A recent or upcoming
-
conduct laboratory-based research focusing on multiple myeloma and its precursor conditions. Based on the mission of the lab, the successful candidate will be responsible for identifying novel biomarkers